Jennifer Leigh McQuade

Dr. McQuade is a melanoma medical oncologist and physician-scientist at MD Anderson hosting a translational research program focused on understanding the interaction between host-level factors, tumor biology, immunity and outcomes. She is published in 41 peer-reviewed original research articles and authored or co-authored on 3 dozen other articles, abstracts and editorials. She has presented at conferences across the nation and has been featured in articles from both The New York Times and The Houston Chronicle for her paper in The Lancet Oncology titled Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.